跳至主要内容
临床试验/CTRI/2020/07/026952
CTRI/2020/07/026952尚未招募2/3 期

Survey on depression, anxiety and stress during Covid-19 in general population of Hassan district and its management with Brahmi (Bacopa monnieri (L.) Pennell)

SDM College of Ayurveda and Hospital1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年1月8日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
发起方
入组人数
200
试验地点
1
主要终点
Reduction in depression, anxiety and stress

研究概览

简要总结

The aim of the study is to understand the prevalence of symptoms of depression, anxiety and stress in general population during COVID-19 in Hassan district and to evaluate the effectiveness of Brahmi capsule in depression, anxiety and stress during COVID-19 in Hassan district. 1000 subjects will be surveyed using DASS 21 scale for 30 days and from that 200 subjects will be administered with Brahmi capsule for a period of 30 days. Later the subjects will be assessed again using DASS 21 for probable reduction in depression, anxiety and stress.

研究设计

研究类型
Interventional
分配方式
Other
盲法
Open Label

入排标准

年龄范围
12.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Subjects within 12 to 60 years of age.

排除标准

  • Subjects below 12 years and above 60 years.

结局指标

主要结局

Reduction in depression, anxiety and stress

时间窗: 60 days

次要结局

  • Survey on the prevalence of depression, anxiety and stress during COVID-19(60 days)

研究者

发起方
SDM College of Ayurveda and Hospital
申办方类型
Private medical college

研究点 (1)

Loading locations...

相似试验